Search by Drug Name or NDC
NDC 63629-9196-01 cholestyramine powder for suspension 4 g/8.78g Details
cholestyramine powder for suspension 4 g/8.78g
cholestyramine powder for suspension is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is CHOLESTYRAMINE.
MedlinePlus Drug Summary
Cholestyramine is used with diet changes (restriction of cholesterol and fat intake) to reduce the amount of cholesterol and certain fatty substances in your blood. Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and, therefore, the oxygen supply to your heart, brain, and other parts of your body. Lowering your blood level of cholesterol and fats may help to prevent heart disease, angina (chest pain), strokes, and heart attacks. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 63629-9196-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cholestyramine Resin
Product Information
| NDC | 63629-9196 |
|---|---|
| Product ID | 63629-9196_e768c7f5-387d-4c3f-adc6-bc8ff15480b4 |
| Associated GPIs | 39100010002905 |
| GCN Sequence Number | 048571 |
| GCN Sequence Number Description | cholestyramine (with sugar) POWDER 4 G ORAL |
| HIC3 | D7L |
| HIC3 Description | BILE SALT SEQUESTRANTS |
| GCN | 14295 |
| HICL Sequence Number | 004851 |
| HICL Sequence Number Description | CHOLESTYRAMINE (WITH SUGAR) |
| Brand/Generic | Generic |
| Proprietary Name | cholestyramine powder for suspension |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | cholestyramine powder for suspension |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | g/8.78g |
| Substance Name | CHOLESTYRAMINE |
| Labeler Name | Bryant Ranch Prepack |
| Pharmaceutical Class | Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211856 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63629-9196-01 (63629919601)
| NDC Package Code | 63629-9196-1 |
|---|---|
| Billing NDC | 63629919601 |
| Package | 368.76 g in 1 JAR (63629-9196-1) |
| Marketing Start Date | 2022-08-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |